WallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock

$213.16-0.71 (-0.33%)
Updated May 6, 2021
VRTX Price
$213.16
Fair Value Price
N/A
Market Cap
$55.41B
52 Week Low
$202.57
52 Week High
$306.08
P/E
20.03x
P/B
6.17x
P/S
8.69x
PEG
5.21x
Dividend Yield
0%
Revenue
$6.41B
Earnings
$2.76B
Gross Margin
88.1%
Operating Margin
52.07%
Profit Margin
43.1%
Debt to Equity
0.35
Operating Cash Flow
$3B
Beta
0.98
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

VRTX Overview

Zen Score

High
Medium
Low
46
Industry average

Reasons for this score

VRTX ($213.16) is trading below its intrinsic value of $343.00, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
VRTX is good value based on its earnings relative to its share price (20.03x), compared to the US market average 27.98x)
Valuation
VRTX is good value based on its earnings relative to its share price (20.03x), compared to the US Biotechnology industry average (66.59x)
Valuation

1 of 11

VRTX News

Valuation

VRTX fair value

Fair Value of VRTX stock based on Discounted Cash Flow (DCF)
Price
$213.16
Fair Value
$237.74
Undervalued by
10.34%
VRTX ($213.16) is trading below its intrinsic value of $343.00, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation

VRTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
20.03x
Industry
66.59x
Market
27.98x
VRTX is good value based on its earnings relative to its share price (20.03x), compared to the US market average 27.98x)
Valuation
VRTX is good value based on its earnings relative to its share price (20.03x), compared to the US Biotechnology industry average (66.59x)
Valuation

VRTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.17x
Industry
6.01x
Market
0.6x
VRTX is poor value based on its book value relative to its share price (6.17x), compared to the US market average (0.6x)
Valuation
VRTX is poor value based on its book value relative to its share price (6.17x), compared to the US Biotechnology industry average (6.01x)
Valuation

VRTX price to earnings growth (PEG)

For valuing profitable companies with growth potential
VRTX is poor value relative to its rate of earnings growth, measured by PEG ratio (5.21x)
Valuation

VRTX's financial health

Profit margin

Revenue
$1.7B
Net Income
$653.1M
Profit Margin
37.9%
VRTX's Earnings (EBIT) of $3.34B can safely cover interest payments on company debt ($898.80M)
Financials
VRTX's profit margin has increased (+11.7%) in the last year from (31.4%) to (43.1%)
Financials

Assets to liabilities

Assets
$12.1B
Liabilities
$3.1B
Debt to equity
0.1
VRTX's short-term assets ($8.54B) exceed its short-term liabilities ($1.94B)
Financials
VRTX's short-term assets ($8.54B) exceed its long-term liabilities ($1.19B)
Financials
VRTX's debt relative to shareholder equity (0.35) has decreased or remained constant compared to 5 years ago (1.43)
Financials
VRTX's debt to equity ratio (0.35) is considered acceptable
Financials

Cash flow

Operating
$921.1M
Investing
-$74.3M
Financing
-$518.7M
VRTX's operating cash flow ($3.36B) is sufficient to service the company's debt ($898.80M)
Financials

Vertex Pharmaceuticals Stock FAQ

What is Vertex Pharmaceuticals's quote symbol?

(NASDAQ: VRTX) Vertex Pharmaceuticals trades on the NASDAQ under the ticker symbol VRTX. Vertex Pharmaceuticals stock quotes can also be displayed as NASDAQ: VRTX.

What is the 52 week high and low for Vertex Pharmaceuticals (NASDAQ: VRTX)?

(NASDAQ: VRTX) Vertex Pharmaceuticals's 52-week high was $306.08, and its 52-week low was $202.57. It is currently -30.36% from its 52-week high and 5.23% from its 52-week low.

How much is Vertex Pharmaceuticals stock worth today?

(NASDAQ: VRTX) Vertex Pharmaceuticals currently has 259,960,062 outstanding shares. With Vertex Pharmaceuticals stock trading at $213.16 per share, the total value of Vertex Pharmaceuticals stock (market capitalization) is $55.41B.

Vertex Pharmaceuticals stock was originally listed at a price of $16.50 in Dec 31, 1997. If you had invested in Vertex Pharmaceuticals stock at $16.50, your return over the last 23 years would have been 1,191.88%, for an annualized return of 11.77%.

How much is Vertex Pharmaceuticals's stock price per share?

(NASDAQ: VRTX) Vertex Pharmaceuticals stock price per share is $213.16 today (as of May 6, 2021).

What is Vertex Pharmaceuticals's Market Cap?

(NASDAQ: VRTX) Vertex Pharmaceuticals's market cap is $55.41B, as of May 9, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vertex Pharmaceuticals's market cap is calculated by multiplying VRTX's current stock price of $213.16 by VRTX's total outstanding shares of 259,960,062.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.